Trials / Conditions / Metastatic Neuroendocrine Tumor
Metastatic Neuroendocrine Tumor
4 registered clinical trials studyying Metastatic Neuroendocrine Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment NCT05724108 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 NCT04234568 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Phase 2 Study of ONC201 in Neuroendocrine Tumors NCT03034200 | Peter Anderson | Phase 2 |
| Active Not Recruiting | Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors NCT01841736 | National Cancer Institute (NCI) | Phase 2 |